Drug
Sulopenem clinical trials
- studies test it
- 4
- open now
- 0
- in phase 3
- 2
- first study started
- 2009
How studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
4 studies that test it; most in 2018 (2)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2018 | 2 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 1
- Phase 3
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses sulopenem is read from its arms, and is right about nine times in ten.
Testing it · 4
- Safety, Tolerability, and Pharmacokinetics of Sulopenem in AdolescentsWithdrawnPhase 1Iterum Therapeutics, International LimitedNCT04700787Written as Sulopenem
- Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in AdultsCompletedPhase 3Iterum Therapeutics, International LimitedNCT03357614Written as Sulopenem
- Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI)CompletedPhase 3Iterum Therapeutics, International LimitedNCT03358576Written as Sulopenem
- A Study Of Intravenous Sulopenem And Oral PF-03709270 In Community Acquired Pneumonia That Requires HospitalizationCompletedPhase 2PfizerNCT00797108Written as sulopenem and PF-03709270
Codes
What other systems call sulopenem · ClinicalTrials.gg INT003746
- UNII (FDA) XX514BJ1XWSULOPENEMConfirmed FDA, Wikidata
- Wikidata Q27294038sulopenemConfirmed FDA, Wikidata
- NCI Thesaurus C84189SulopenemOne source FDA
- DrugBank DB15284One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | XX514BJ1XW | SULOPENEM | Confirmed FDA, Wikidata |
| Wikidata | Q27294038 | sulopenem | Confirmed FDA, Wikidata |
| NCI Thesaurus | C84189 | Sulopenem | One source FDA |
| DrugBank | DB15284 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.